nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—Ketoconazole—CYP2A6—hepatitis B	0.00716	1	CrCbGaD
Posaconazole—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00481	0.00485	CcSEcCtD
Posaconazole—Pancreatitis—Entecavir—hepatitis B	0.00474	0.00477	CcSEcCtD
Posaconazole—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00462	0.00466	CcSEcCtD
Posaconazole—Pain in extremity—Telbivudine—hepatitis B	0.0046	0.00463	CcSEcCtD
Posaconazole—Migraine—Telbivudine—hepatitis B	0.00452	0.00456	CcSEcCtD
Posaconazole—Neutropenia—Entecavir—hepatitis B	0.00452	0.00455	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Entecavir—hepatitis B	0.00449	0.00453	CcSEcCtD
Posaconazole—Rhinorrhoea—Lamivudine—hepatitis B	0.0044	0.00444	CcSEcCtD
Posaconazole—Hyperglycaemia—Entecavir—hepatitis B	0.00436	0.00439	CcSEcCtD
Posaconazole—Dysphonia—Lamivudine—hepatitis B	0.00434	0.00437	CcSEcCtD
Posaconazole—Blood disorder—Lamivudine—hepatitis B	0.00427	0.0043	CcSEcCtD
Posaconazole—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00427	0.0043	CcSEcCtD
Posaconazole—Renal failure—Entecavir—hepatitis B	0.00424	0.00427	CcSEcCtD
Posaconazole—Abdominal pain upper—Telbivudine—hepatitis B	0.0042	0.00423	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00414	0.00417	CcSEcCtD
Posaconazole—Cramp muscle—Telbivudine—hepatitis B	0.00414	0.00417	CcSEcCtD
Posaconazole—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00413	0.00416	CcSEcCtD
Posaconazole—Haematuria—Entecavir—hepatitis B	0.00411	0.00414	CcSEcCtD
Posaconazole—Nasopharyngitis—Telbivudine—hepatitis B	0.00411	0.00414	CcSEcCtD
Posaconazole—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0041	0.00413	CcSEcCtD
Posaconazole—Hepatobiliary disease—Entecavir—hepatitis B	0.00408	0.00411	CcSEcCtD
Posaconazole—Gastritis—Telbivudine—hepatitis B	0.00407	0.0041	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00405	0.00408	CcSEcCtD
Posaconazole—Muscular weakness—Telbivudine—hepatitis B	0.00405	0.00408	CcSEcCtD
Posaconazole—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00401	0.00404	CcSEcCtD
Posaconazole—Abdominal distension—Telbivudine—hepatitis B	0.004	0.00403	CcSEcCtD
Posaconazole—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00398	0.00401	CcSEcCtD
Posaconazole—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00395	0.00397	CcSEcCtD
Posaconazole—Hepatitis—Entecavir—hepatitis B	0.00387	0.0039	CcSEcCtD
Posaconazole—Drug interaction—Lamivudine—hepatitis B	0.00385	0.00387	CcSEcCtD
Posaconazole—Oedema peripheral—Entecavir—hepatitis B	0.00381	0.00384	CcSEcCtD
Posaconazole—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00378	0.0038	CcSEcCtD
Posaconazole—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00377	0.0038	CcSEcCtD
Posaconazole—Hearing impaired—Lamivudine—hepatitis B	0.00375	0.00377	CcSEcCtD
Posaconazole—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00375	0.00377	CcSEcCtD
Posaconazole—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00373	0.00376	CcSEcCtD
Posaconazole—Neutropenia—Telbivudine—hepatitis B	0.00371	0.00374	CcSEcCtD
Posaconazole—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00371	0.00374	CcSEcCtD
Posaconazole—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0037	0.00373	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00369	0.00372	CcSEcCtD
Posaconazole—Inflammation—Lamivudine—hepatitis B	0.00368	0.0037	CcSEcCtD
Posaconazole—Vasculitis—Lamivudine—hepatitis B	0.00366	0.00368	CcSEcCtD
Posaconazole—Muscle twitching—Lamivudine—hepatitis B	0.00363	0.00366	CcSEcCtD
Posaconazole—Musculoskeletal pain—Lamivudine—hepatitis B	0.00361	0.00364	CcSEcCtD
Posaconazole—Eructation—Lamivudine—hepatitis B	0.0035	0.00353	CcSEcCtD
Posaconazole—Immune system disorder—Entecavir—hepatitis B	0.0035	0.00352	CcSEcCtD
Posaconazole—Renal failure—Telbivudine—hepatitis B	0.00348	0.00351	CcSEcCtD
Posaconazole—Neuropathy peripheral—Telbivudine—hepatitis B	0.00347	0.0035	CcSEcCtD
Posaconazole—Alopecia—Entecavir—hepatitis B	0.00342	0.00344	CcSEcCtD
Posaconazole—Mental disorder—Entecavir—hepatitis B	0.00339	0.00341	CcSEcCtD
Posaconazole—Malnutrition—Entecavir—hepatitis B	0.00337	0.00339	CcSEcCtD
Posaconazole—Neuropathy—Lamivudine—hepatitis B	0.00335	0.00337	CcSEcCtD
Posaconazole—Aplastic anaemia—Lamivudine—hepatitis B	0.00335	0.00337	CcSEcCtD
Posaconazole—Photophobia—Lamivudine—hepatitis B	0.00335	0.00337	CcSEcCtD
Posaconazole—Hepatobiliary disease—Telbivudine—hepatitis B	0.00335	0.00337	CcSEcCtD
Posaconazole—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00329	0.00331	CcSEcCtD
Posaconazole—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00324	0.00326	CcSEcCtD
Posaconazole—Mouth ulceration—Lamivudine—hepatitis B	0.00323	0.00325	CcSEcCtD
Posaconazole—Back pain—Adefovir Dipivoxil—hepatitis B	0.00318	0.0032	CcSEcCtD
Posaconazole—Hepatitis—Telbivudine—hepatitis B	0.00318	0.0032	CcSEcCtD
Posaconazole—Hypoaesthesia—Telbivudine—hepatitis B	0.00316	0.00319	CcSEcCtD
Posaconazole—Pharyngitis—Telbivudine—hepatitis B	0.00315	0.00318	CcSEcCtD
Posaconazole—Connective tissue disorder—Telbivudine—hepatitis B	0.00312	0.00315	CcSEcCtD
Posaconazole—Sepsis—Lamivudine—hepatitis B	0.0031	0.00312	CcSEcCtD
Posaconazole—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00304	0.00306	CcSEcCtD
Posaconazole—Lymphadenopathy—Lamivudine—hepatitis B	0.00304	0.00306	CcSEcCtD
Posaconazole—Leukopenia—Entecavir—hepatitis B	0.00302	0.00304	CcSEcCtD
Posaconazole—Sleep disorder—Lamivudine—hepatitis B	0.00299	0.00301	CcSEcCtD
Posaconazole—Gastroenteritis—Lamivudine—hepatitis B	0.00292	0.00294	CcSEcCtD
Posaconazole—Deafness—Lamivudine—hepatitis B	0.00289	0.00292	CcSEcCtD
Posaconazole—Cough—Adefovir Dipivoxil—hepatitis B	0.00287	0.00289	CcSEcCtD
Posaconazole—Mediastinal disorder—Telbivudine—hepatitis B	0.00286	0.00289	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00285	0.00287	CcSEcCtD
Posaconazole—Injury—Lamivudine—hepatitis B	0.00282	0.00284	CcSEcCtD
Posaconazole—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0028	0.00282	CcSEcCtD
Posaconazole—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0028	0.00282	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00278	0.0028	CcSEcCtD
Posaconazole—Malnutrition—Telbivudine—hepatitis B	0.00277	0.00279	CcSEcCtD
Posaconazole—Infection—Entecavir—hepatitis B	0.00273	0.00275	CcSEcCtD
Posaconazole—Renal impairment—Lamivudine—hepatitis B	0.00272	0.00274	CcSEcCtD
Posaconazole—Thirst—Lamivudine—hepatitis B	0.00272	0.00274	CcSEcCtD
Posaconazole—Dysgeusia—Telbivudine—hepatitis B	0.00271	0.00273	CcSEcCtD
Posaconazole—Nervous system disorder—Entecavir—hepatitis B	0.0027	0.00272	CcSEcCtD
Posaconazole—Back pain—Telbivudine—hepatitis B	0.00268	0.0027	CcSEcCtD
Posaconazole—Skin disorder—Entecavir—hepatitis B	0.00267	0.00269	CcSEcCtD
Posaconazole—Muscle spasms—Telbivudine—hepatitis B	0.00266	0.00268	CcSEcCtD
Posaconazole—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00263	0.00265	CcSEcCtD
Posaconazole—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00263	0.00265	CcSEcCtD
Posaconazole—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00261	0.00262	CcSEcCtD
Posaconazole—Ill-defined disorder—Telbivudine—hepatitis B	0.00257	0.00259	CcSEcCtD
Posaconazole—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00256	0.00258	CcSEcCtD
Posaconazole—Affect lability—Lamivudine—hepatitis B	0.00255	0.00257	CcSEcCtD
Posaconazole—Migraine—Lamivudine—hepatitis B	0.00255	0.00257	CcSEcCtD
Posaconazole—Malaise—Telbivudine—hepatitis B	0.0025	0.00251	CcSEcCtD
Posaconazole—Insomnia—Entecavir—hepatitis B	0.00249	0.0025	CcSEcCtD
Posaconazole—Mood swings—Lamivudine—hepatitis B	0.00245	0.00247	CcSEcCtD
Posaconazole—Somnolence—Entecavir—hepatitis B	0.00244	0.00246	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00244	0.00246	CcSEcCtD
Posaconazole—Dyspepsia—Entecavir—hepatitis B	0.00242	0.00244	CcSEcCtD
Posaconazole—Cough—Telbivudine—hepatitis B	0.00241	0.00243	CcSEcCtD
Posaconazole—Dehydration—Lamivudine—hepatitis B	0.00241	0.00243	CcSEcCtD
Posaconazole—Liver function test abnormal—Lamivudine—hepatitis B	0.00239	0.00241	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Entecavir—hepatitis B	0.00237	0.00239	CcSEcCtD
Posaconazole—Fatigue—Entecavir—hepatitis B	0.00237	0.00239	CcSEcCtD
Posaconazole—Abdominal pain upper—Lamivudine—hepatitis B	0.00237	0.00238	CcSEcCtD
Posaconazole—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00236	0.00238	CcSEcCtD
Posaconazole—Chest pain—Telbivudine—hepatitis B	0.00236	0.00237	CcSEcCtD
Posaconazole—Myalgia—Telbivudine—hepatitis B	0.00236	0.00237	CcSEcCtD
Posaconazole—Arthralgia—Telbivudine—hepatitis B	0.00236	0.00237	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00234	0.00236	CcSEcCtD
Posaconazole—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00233	0.00235	CcSEcCtD
Posaconazole—Cramp muscle—Lamivudine—hepatitis B	0.00233	0.00235	CcSEcCtD
Posaconazole—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00233	0.00235	CcSEcCtD
Posaconazole—Discomfort—Telbivudine—hepatitis B	0.00233	0.00234	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00232	0.00233	CcSEcCtD
Posaconazole—Nasopharyngitis—Lamivudine—hepatitis B	0.00232	0.00233	CcSEcCtD
Posaconazole—Muscular weakness—Lamivudine—hepatitis B	0.00228	0.0023	CcSEcCtD
Posaconazole—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00228	0.0023	CcSEcCtD
Posaconazole—Abdominal distension—Lamivudine—hepatitis B	0.00225	0.00227	CcSEcCtD
Posaconazole—Gastrointestinal pain—Entecavir—hepatitis B	0.00225	0.00226	CcSEcCtD
Posaconazole—Dysphagia—Lamivudine—hepatitis B	0.00224	0.00225	CcSEcCtD
Posaconazole—Nervous system disorder—Telbivudine—hepatitis B	0.00221	0.00223	CcSEcCtD
Posaconazole—Thrombocytopenia—Telbivudine—hepatitis B	0.00221	0.00223	CcSEcCtD
Posaconazole—Pancreatitis—Lamivudine—hepatitis B	0.00219	0.00221	CcSEcCtD
Posaconazole—Skin disorder—Telbivudine—hepatitis B	0.00219	0.00221	CcSEcCtD
Posaconazole—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00219	0.00221	CcSEcCtD
Posaconazole—Sweating increased—Lamivudine—hepatitis B	0.00218	0.0022	CcSEcCtD
Posaconazole—Abdominal pain—Entecavir—hepatitis B	0.00217	0.00219	CcSEcCtD
Posaconazole—Body temperature increased—Entecavir—hepatitis B	0.00217	0.00219	CcSEcCtD
Posaconazole—Pancytopenia—Lamivudine—hepatitis B	0.00213	0.00214	CcSEcCtD
Posaconazole—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00212	0.00214	CcSEcCtD
Posaconazole—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00212	0.00214	CcSEcCtD
Posaconazole—Dysuria—Lamivudine—hepatitis B	0.00209	0.00211	CcSEcCtD
Posaconazole—Neutropenia—Lamivudine—hepatitis B	0.00209	0.00211	CcSEcCtD
Posaconazole—Pollakiuria—Lamivudine—hepatitis B	0.00207	0.00208	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00206	0.00207	CcSEcCtD
Posaconazole—Insomnia—Telbivudine—hepatitis B	0.00204	0.00206	CcSEcCtD
Posaconazole—Paraesthesia—Telbivudine—hepatitis B	0.00203	0.00204	CcSEcCtD
Posaconazole—Hyperglycaemia—Lamivudine—hepatitis B	0.00202	0.00203	CcSEcCtD
Posaconazole—Dyspepsia—Telbivudine—hepatitis B	0.00199	0.002	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00198	0.00199	CcSEcCtD
Posaconazole—Asthenia—Entecavir—hepatitis B	0.00197	0.00199	CcSEcCtD
Posaconazole—Renal failure—Lamivudine—hepatitis B	0.00196	0.00198	CcSEcCtD
Posaconazole—Neuropathy peripheral—Lamivudine—hepatitis B	0.00196	0.00197	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00195	0.00196	CcSEcCtD
Posaconazole—Fatigue—Telbivudine—hepatitis B	0.00195	0.00196	CcSEcCtD
Posaconazole—Stomatitis—Lamivudine—hepatitis B	0.00195	0.00196	CcSEcCtD
Posaconazole—Jaundice—Lamivudine—hepatitis B	0.00195	0.00196	CcSEcCtD
Posaconazole—Pain—Telbivudine—hepatitis B	0.00193	0.00195	CcSEcCtD
Posaconazole—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00192	0.00194	CcSEcCtD
Posaconazole—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0019	0.00191	CcSEcCtD
Posaconazole—Hepatobiliary disease—Lamivudine—hepatitis B	0.00189	0.0019	CcSEcCtD
Posaconazole—Epistaxis—Lamivudine—hepatitis B	0.00188	0.0019	CcSEcCtD
Posaconazole—Diarrhoea—Entecavir—hepatitis B	0.00188	0.00189	CcSEcCtD
Posaconazole—Sinusitis—Lamivudine—hepatitis B	0.00187	0.00189	CcSEcCtD
Posaconazole—Agranulocytosis—Lamivudine—hepatitis B	0.00186	0.00188	CcSEcCtD
Posaconazole—Feeling abnormal—Telbivudine—hepatitis B	0.00186	0.00187	CcSEcCtD
Posaconazole—Gastrointestinal pain—Telbivudine—hepatitis B	0.00185	0.00186	CcSEcCtD
Posaconazole—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00184	0.00185	CcSEcCtD
Posaconazole—Dizziness—Entecavir—hepatitis B	0.00182	0.00183	CcSEcCtD
Posaconazole—Rhinitis—Lamivudine—hepatitis B	0.0018	0.00181	CcSEcCtD
Posaconazole—Hepatitis—Lamivudine—hepatitis B	0.00179	0.0018	CcSEcCtD
Posaconazole—Abdominal pain—Telbivudine—hepatitis B	0.00179	0.0018	CcSEcCtD
Posaconazole—Body temperature increased—Telbivudine—hepatitis B	0.00179	0.0018	CcSEcCtD
Posaconazole—Hypoaesthesia—Lamivudine—hepatitis B	0.00178	0.0018	CcSEcCtD
Posaconazole—Pharyngitis—Lamivudine—hepatitis B	0.00178	0.00179	CcSEcCtD
Posaconazole—Connective tissue disorder—Lamivudine—hepatitis B	0.00176	0.00177	CcSEcCtD
Posaconazole—Vomiting—Entecavir—hepatitis B	0.00175	0.00176	CcSEcCtD
Posaconazole—Rash—Entecavir—hepatitis B	0.00173	0.00175	CcSEcCtD
Posaconazole—Dermatitis—Entecavir—hepatitis B	0.00173	0.00174	CcSEcCtD
Posaconazole—Headache—Entecavir—hepatitis B	0.00172	0.00173	CcSEcCtD
Posaconazole—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00171	0.00172	CcSEcCtD
Posaconazole—Erythema multiforme—Lamivudine—hepatitis B	0.00169	0.00171	CcSEcCtD
Posaconazole—Rash—Adefovir Dipivoxil—hepatitis B	0.00169	0.0017	CcSEcCtD
Posaconazole—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00169	0.0017	CcSEcCtD
Posaconazole—Headache—Adefovir Dipivoxil—hepatitis B	0.00168	0.00169	CcSEcCtD
Posaconazole—Nausea—Entecavir—hepatitis B	0.00163	0.00164	CcSEcCtD
Posaconazole—Asthenia—Telbivudine—hepatitis B	0.00162	0.00163	CcSEcCtD
Posaconazole—Immune system disorder—Lamivudine—hepatitis B	0.00162	0.00163	CcSEcCtD
Posaconazole—Mediastinal disorder—Lamivudine—hepatitis B	0.00161	0.00163	CcSEcCtD
Posaconazole—Chills—Lamivudine—hepatitis B	0.00161	0.00162	CcSEcCtD
Posaconazole—Pruritus—Telbivudine—hepatitis B	0.0016	0.00161	CcSEcCtD
Posaconazole—Nausea—Adefovir Dipivoxil—hepatitis B	0.00159	0.0016	CcSEcCtD
Posaconazole—Alopecia—Lamivudine—hepatitis B	0.00158	0.00159	CcSEcCtD
Posaconazole—Malnutrition—Lamivudine—hepatitis B	0.00156	0.00157	CcSEcCtD
Posaconazole—Erythema—Lamivudine—hepatitis B	0.00156	0.00157	CcSEcCtD
Posaconazole—Diarrhoea—Telbivudine—hepatitis B	0.00155	0.00156	CcSEcCtD
Posaconazole—Flatulence—Lamivudine—hepatitis B	0.00154	0.00155	CcSEcCtD
Posaconazole—Dysgeusia—Lamivudine—hepatitis B	0.00153	0.00154	CcSEcCtD
Posaconazole—Back pain—Lamivudine—hepatitis B	0.00151	0.00152	CcSEcCtD
Posaconazole—Muscle spasms—Lamivudine—hepatitis B	0.0015	0.00151	CcSEcCtD
Posaconazole—Dizziness—Telbivudine—hepatitis B	0.00149	0.0015	CcSEcCtD
Posaconazole—Tremor—Lamivudine—hepatitis B	0.00146	0.00147	CcSEcCtD
Posaconazole—Ill-defined disorder—Lamivudine—hepatitis B	0.00145	0.00146	CcSEcCtD
Posaconazole—Anaemia—Lamivudine—hepatitis B	0.00144	0.00145	CcSEcCtD
Posaconazole—Vomiting—Telbivudine—hepatitis B	0.00144	0.00145	CcSEcCtD
Posaconazole—Rash—Telbivudine—hepatitis B	0.00142	0.00143	CcSEcCtD
Posaconazole—Dermatitis—Telbivudine—hepatitis B	0.00142	0.00143	CcSEcCtD
Posaconazole—Headache—Telbivudine—hepatitis B	0.00141	0.00143	CcSEcCtD
Posaconazole—Malaise—Lamivudine—hepatitis B	0.00141	0.00142	CcSEcCtD
Posaconazole—Vertigo—Lamivudine—hepatitis B	0.0014	0.00141	CcSEcCtD
Posaconazole—Syncope—Lamivudine—hepatitis B	0.0014	0.00141	CcSEcCtD
Posaconazole—Leukopenia—Lamivudine—hepatitis B	0.0014	0.00141	CcSEcCtD
Posaconazole—Loss of consciousness—Lamivudine—hepatitis B	0.00137	0.00138	CcSEcCtD
Posaconazole—Cough—Lamivudine—hepatitis B	0.00136	0.00137	CcSEcCtD
Posaconazole—Convulsion—Lamivudine—hepatitis B	0.00135	0.00136	CcSEcCtD
Posaconazole—Nausea—Telbivudine—hepatitis B	0.00134	0.00135	CcSEcCtD
Posaconazole—Myalgia—Lamivudine—hepatitis B	0.00133	0.00134	CcSEcCtD
Posaconazole—Arthralgia—Lamivudine—hepatitis B	0.00133	0.00134	CcSEcCtD
Posaconazole—Chest pain—Lamivudine—hepatitis B	0.00133	0.00134	CcSEcCtD
Posaconazole—Anxiety—Lamivudine—hepatitis B	0.00132	0.00133	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00132	0.00133	CcSEcCtD
Posaconazole—Discomfort—Lamivudine—hepatitis B	0.00131	0.00132	CcSEcCtD
Posaconazole—Dry mouth—Lamivudine—hepatitis B	0.0013	0.00131	CcSEcCtD
Posaconazole—Confusional state—Lamivudine—hepatitis B	0.00128	0.00129	CcSEcCtD
Posaconazole—Oedema—Lamivudine—hepatitis B	0.00127	0.00128	CcSEcCtD
Posaconazole—Infection—Lamivudine—hepatitis B	0.00126	0.00127	CcSEcCtD
Posaconazole—Shock—Lamivudine—hepatitis B	0.00125	0.00126	CcSEcCtD
Posaconazole—Nervous system disorder—Lamivudine—hepatitis B	0.00125	0.00126	CcSEcCtD
Posaconazole—Thrombocytopenia—Lamivudine—hepatitis B	0.00125	0.00126	CcSEcCtD
Posaconazole—Skin disorder—Lamivudine—hepatitis B	0.00124	0.00125	CcSEcCtD
Posaconazole—Hyperhidrosis—Lamivudine—hepatitis B	0.00123	0.00124	CcSEcCtD
Posaconazole—Anorexia—Lamivudine—hepatitis B	0.00121	0.00122	CcSEcCtD
Posaconazole—Hypotension—Lamivudine—hepatitis B	0.00119	0.0012	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00116	0.00117	CcSEcCtD
Posaconazole—Insomnia—Lamivudine—hepatitis B	0.00115	0.00116	CcSEcCtD
Posaconazole—Paraesthesia—Lamivudine—hepatitis B	0.00114	0.00115	CcSEcCtD
Posaconazole—Dyspnoea—Lamivudine—hepatitis B	0.00113	0.00114	CcSEcCtD
Posaconazole—Somnolence—Lamivudine—hepatitis B	0.00113	0.00114	CcSEcCtD
Posaconazole—Dyspepsia—Lamivudine—hepatitis B	0.00112	0.00113	CcSEcCtD
Posaconazole—Decreased appetite—Lamivudine—hepatitis B	0.00111	0.00111	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0011	0.00111	CcSEcCtD
Posaconazole—Fatigue—Lamivudine—hepatitis B	0.0011	0.00111	CcSEcCtD
Posaconazole—Pain—Lamivudine—hepatitis B	0.00109	0.0011	CcSEcCtD
Posaconazole—Constipation—Lamivudine—hepatitis B	0.00109	0.0011	CcSEcCtD
Posaconazole—Feeling abnormal—Lamivudine—hepatitis B	0.00105	0.00106	CcSEcCtD
Posaconazole—Gastrointestinal pain—Lamivudine—hepatitis B	0.00104	0.00105	CcSEcCtD
Posaconazole—Urticaria—Lamivudine—hepatitis B	0.00101	0.00102	CcSEcCtD
Posaconazole—Body temperature increased—Lamivudine—hepatitis B	0.00101	0.00101	CcSEcCtD
Posaconazole—Abdominal pain—Lamivudine—hepatitis B	0.00101	0.00101	CcSEcCtD
Posaconazole—Hypersensitivity—Lamivudine—hepatitis B	0.000938	0.000944	CcSEcCtD
Posaconazole—Asthenia—Lamivudine—hepatitis B	0.000913	0.00092	CcSEcCtD
Posaconazole—Pruritus—Lamivudine—hepatitis B	0.0009	0.000907	CcSEcCtD
Posaconazole—Diarrhoea—Lamivudine—hepatitis B	0.000871	0.000877	CcSEcCtD
Posaconazole—Dizziness—Lamivudine—hepatitis B	0.000842	0.000848	CcSEcCtD
Posaconazole—Vomiting—Lamivudine—hepatitis B	0.000809	0.000815	CcSEcCtD
Posaconazole—Rash—Lamivudine—hepatitis B	0.000803	0.000808	CcSEcCtD
Posaconazole—Dermatitis—Lamivudine—hepatitis B	0.000802	0.000808	CcSEcCtD
Posaconazole—Headache—Lamivudine—hepatitis B	0.000797	0.000803	CcSEcCtD
Posaconazole—Nausea—Lamivudine—hepatitis B	0.000756	0.000761	CcSEcCtD
